Mapping, monitoring, and surveillance of neglected tropical diseases: towards a policy framework

The Lancet

Volumn 375, Issue 9710, 2010, Pages 231-238

  Baker, MC ^a   Mathieu, E ^b   Fleming, FM ^c   Deming, M ^b   King, JD ^d   Garba, A ^e   Koroma, JB ^f   Bockarie, M ^g   Kabore, A ^h   Sankara, DP ^a   Molyneux, DH ^g  

^a RTI INTERNATIONAL   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d CARTER CENTER   (United States)

^e RISEAL   (Niger)

^f MINISTRY OF HEALTH AND SANITATION   (Sierra Leone)

^g LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^h Liverpool Associates in Tropical Health   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTHELMINTIC AGENT; ANTIBIOTIC AGENT; AZITHROMYCIN; IVERMECTIN; PRAZIQUANTEL;

BIOLOGICAL MONITORING; HEALTH CARE POLICY; HEALTH SURVEY; HELMINTHIASIS; HUMAN; INFECTION PREVENTION; LYMPHATIC FILARIASIS; ONCHOCERCIASIS; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; SCHISTOSOMIASIS; TRACHOMA; TROPICAL DISEASE;

EID: 74249087279     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)61458-6     Document Type: Review

References (82)

1. Molyneux D.H., Hotez P.J., and Fenwick A. "Rapid-impact interventions": how a policy of integrated control for Africa's neglected tropical diseases could benefit the poor. PLoS Med 2 (2005) e336
2. WHO. Preventive chemotherapy in human helminthiasis. Coordinated use of anthelminthic drugs in control interventions: a manual for health professionals and programme managers (2006), World Health Organization, Geneva
3. Hotez P.J., Molyneux D.H., Fenwick A., et al. Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria. PLoS Med 3 (2006) e102
4. Butler D. Neglected disease boost. Nature 457 (2009) 772-773
5. Utzinger J., and Savigny D. Control of neglected tropical disease: Integrated chemotherapy and beyond. PLoS Med 3 (2006) e112
6. Onapa A.W., Simonsen P.E., Baehr I., et al. Rapid assessment of the geographical distribution of lymphatic filariasis in Uganda, by screening of schoolchildren for circulating filarial antigens. Ann Trop Med Parasitol 99 (2005) 141-153
7. Gyapong J.O., Kyelem D., and Kleinschmidt I. The use of spatial analysis in mapping the distribution of bancroftian filariasis in four West African countries. Ann Trop Med Parasitol 96 (2002) 695-705
8. Gyapong J.O., and Remme J.H.F. The use of grid sampling methodology for rapid assessment of the distribution of bancroftian filariais. Trans R Soc Trop Med Hyg 95 (2001) 681-686
9. de Rochars M.B., Milord M.D., St Jean Y., et al. Geographic distribution of lymphatic filariasis in Haiti. Am J Trop Med Hyg 71 (2004) 598-601
10. WHO. Monitoring and epidemiological assessment of the programme to eliminate lymphatic filariasis at implementation unit level/WHO/CDS/CPE/CEE/2005.50 (2005), World Health Organization, Geneva
11. In: White G.B., and Nathan M.B. (Eds). The elimination of lymphatic filariasis: public health challenges and the role of vector control. Ann Trop Med Parasitol 96 suppl 2 (2002) S3-S164
12. Ottesen E.A. Lymphatic filariasis: treatment, control and elimination. Adv Parasitol 61 (2006) 395-441
13. Bockarie M.J., and Molyneux D.H. The end of lymphatic filariasis?. BMJ 338 (2009) b1686
14. Ngoumou P., Walsh J.F., and Mace J.M. A rapid mapping technique for the prevalence and distribution of onchocerciasis: a Cameroon case study. Ann Trop Med Parasitol 88 (1994) 463-474
15. Ngoumou P., and Walsh J.F. Manual for the rapid epidemiological mapping of onchocerciasis (1993), World Health Organization, Geneva
16. Noma M., BE N.B., Nutall I., et al. Rapid epidemiological mapping of onchocerciasis (REMO): its application by the African Programme for Onchocerciasis Control (APOC). Ann Trop Med Parasitol 96 suppl 1 (2002) S29-S39
17. WHO. Procedural manual for ivermectin distribution programs. In: Duke B., and Dadzie K.Y. (Eds). Coordination Group for Ivermectin Distribution and WHO Programme for the Prevention of Blindness (1993), World Health Organizaion, Geneva
18. Richards F., Boatin B., Sauerbrey M., and Seketeli A. Control of onchocerciasis today: status and challenges. Trends Parasitol 17 (2001) 558-563
19. APOC/WHO. Community-directed treatment with ivermectin (CDTI). A practical guide for trainers of community-directed distributors (1998), African Programme for Onchocerciasis Control/World Health Organization (APOC/WHO), Ouagadougou/Geneva. http://www.who.int/entity/apoc/publications/guidefortrainers_cdds/en/ (accessed July 31, 2009).
20. APOC. Community self-monitoring of ivermectin treatment. A facilitator's guide for supervisors of community-directed treatment with ivermectin (CDTI) (2002), African Programme for Onchocerciasis Control (APOC)/World Health Organization, Ouagadougou/Geneva. http://www.who.int/entity/apoc/publications/selfmonitoring/en/ (accessed July 31, 2009).
21. APOC/WHO. Independent participatory monitoring of CDTI projects. Guidelines and instruments (2002), African Programme for Onchocerciasis Control/World Health Organization, Ouagadougou/Geneva. http://www.who.int/entity/apoc/publications/cdti_monitoring/en/ (accessed July 31, 2009).
22. WHO. WHO Expert Committee on Onchocerciasis, Third report. WHO Technical Report Series, number 752 (1987), World Health Organization, Geneva
23. WHO. Onchocerciasis and its control: report of a WHO Expert Committee on Onchocerciasis Control. WHO Expert Committee on Onchocerciasis Control (1995), World Health Organization, Geneva
24. Amazigo U., Okeibunor J., Matovu V., Zouré H., Bump J., and Seketeli A. Performance of predictors: evaluating sustainability in community-directed treatment projects of the African programme for onchocerciasis control. Soc Sci Med 64 (2007) 2070-2082
25. Murdoch M.E., Asuzu M.C., Hagan M., et al. Onchocerciasis: the clinical and epidemiological burden of skin disease in Africa. Ann Trop Med Parasitol 96 (2002) 283-296
26. Gonzalez R.J., Cruz-Ortiz N., Rizzo N., et al. Successful interruption of transmission of Onchocera vlovulus in the Escuintla-Guatemala focus, Guatemala. PLoS Negl Trop Dis 3 (2009) e404
27. WHO. Prevention and control of schistosomiasis and soil-transmitted helminthiasis. Report of a WHO Expert Committee. WHO Technical Report Series 912 (2002), World Health Organization, Geneva
28. Montresor A., Crompton D.W.T., Gyorkos T.W., and Savioli L. Helminth control in school-age children: a guide for managers of control programmes (2002), World Health Organization, Geneva. http://www.who.int/entity/wormcontrol/documents/en/HCSOFC.pdf (accessed July 31, 2009).
29. Montresor A., Crompton D.W.T., Hall A., Bundy D., and Savioli L. Guidelines for the evaluation of soil-transmitted helminths and schistosomiasis at the community level (1998), World Health Organization, Geneva
30. Montresor A., Gyorkos T.W., Crompton D.W.T., Savioli L., and Bundy D. Monitoring helminth control programmes: guidelines for monitoring the impact of control programmes aimed at reducing morbidity caused by soil-transmitted helminths and schistosomes, with particular reference to school-age children (1999), World Health Organization, Geneva. http://whqlibdoc.who.int/hq/1999/WHO_CDS_CPC_SIP_99.3.pdf (accessed Aug 26, 2009).
31. Richter J., Hatz C., Campagne G., Bergquist N., and Jenkins J. Ultrasound in Schistosomiasis: A Practical Guide to the Standardized Use of Ultrasonography for the Assessment of Schistosomiasis-Related Morbidity (2000), World Health Organization, Geneva. http://whqlibdoc.who.int/hq/2000/TDR_STR_SCH_00.1.pdf (accessed Aug 26, 2009).
32. WHO. Trachoma control. A guide for programme managers (2006), World Health Organization, Geneva. http://www.who.int/blindness/publications/tcm%20who_pbd_get_06_1.pdf (accessed July 31, 2009).
33. Resnikoff S., Huguet P., and Mariotti S.P. Certification of the elimination of blinding trachoma by the World Health Organization. Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique 84 (2007) 59-68
34. Mariotti S.P., and Pascolini D. Rose-Nussbaumer J. Trachoma: global magnitude of a preventable cause of blindness. Br J Ophthalmol 93 (2009) 563-568
35. WHO. Soil transmitted helminthiasis. Progress report on number of children treated with anthihelminthic drugs: an update towards 2010 global target. Wkly Epidemiol Rec 83 (2008) 237-252
36. World Health Organization. Global programme to eliminate lymphatic filariasis. Progress report on mass drug administration in 2007. Wkly Epidemiol Rec 83 (2008) 333-348
37. Thylefors B., and Alleman M. Towards the elimination of onchocerciasis. Ann Trop Med Parasitol 100 (2006) 733-746
38. Brooker S., Rowlands M., Haller L., Savioli L., and Bundy D. Towards an atlas of human helminth infection in sub-Saharan Africa: the use of geographical information systems (GIS). Parasitol Today 16 (2000) 303-307
39. Molyneux D.H. Filaria control and elimination: diagnostic, monitoring and surveillance needs. Trans R Soc Trop Med Hyg 103 (2009) 338-341
40. Remme J.H.F. The African Programme for Onchocerciasis control: preparing for launch. Parasitol Today 11 (1995) 399-402
41. Gardon J., Gardon-Wendel N., Demanga-Ngangue N., et al. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet 350 (1997) 18-22
42. Thomson M.C., Obsomer V., Dunne M., et al. Satellite mapping of Loa loa prevalence in relation to ivermectin use in west and central Africa. Lancet 356 (2000) 1077-1078
43. Takougang I., Meremikwu M., Wandji S., et al. Rapid assessment method for prevalence and intensity of Loa loa infection. Bull World Health Organ 80 (2002) 852-858
44. Weil G.J., and Ramzy R.M. Diagnostic tools for filariasis elimination programs. Trends Parasitol 23 (2006) 78-82
45. Lengeler C., Utzinger J., and Tanner M. Questionnaires for rapid screening of schistosomiasis in sub-Sahran Africa. Bull World Health Organ 80 (2002) 235-242
46. Ansell J., and Guyatt H.L. Comparative cost-effectiveness of diagnostic tests for urinary schistosomiasis and the implications for school health programmes. Ann Trop Med Parasitol 96 (2002) 145-153
47. Clements A., Brooker S., Nyandindi U., Fenwick A., and Blair L. Bayesian spatial analysis of a national urinary schistosomiasis questionnaire to assist geographic targeting of schistosomiasis control in Tanzania, East Africa. Int J Parasitol 38 (2008) 401-415
48. Brooker S., Kabatereine N.B., Gyapong J.O., Stothard J.R., and Utzinger J. Rapid mapping of schistosomiasis and other neglected tropical diseases in the context of integrated control programmes in Africa. Parasitology 19 (2009) 1-12
49. Brooker S., Kabatereine N.B., Myatt M., Stothard J.R., and Fenwick A. Rapid Assessment of Schistosoma mansoni: the validity, applicability and cost-effectiveness of the lot quality assurance sampling method in Uganda. Trop Med Int Health 10 (2005) 647-658
50. Stothard J.R., Kabatereine N.B., Tukahebwe E.M., et al. Use of circulating cathodic antigen (CCA) dipsticks for detection of intestinal and urinary schistosomiasis. Acta Trop 97 (2006) 219-228
51. Legesse M., and Erko B. Field-based evaluation of a reagent strip test for diagnosis of Schistosoma mansoni by detecting circulating cathodic antigen in urine before and after chemotherapy. Trans R Soc Trop Med Hyg 101 (2007) 668-673
52. Thylefors B., Dawson C.R., Jones B.R., West S.K., and Taylor H.R. A simple system for the assessment of trachoma and its complications. Bull World Health Organ 65 (1987) 477-483
53. Miller K., Schmidt G., Melese M., et al. How reliable is the clinical exam in detecting ocular chlamydial infection?. Ophthalmic Epidemiol 11 (2004) 255-262
54. Mabey D., Solomon A., and Foster A. Trachoma. Lancet 362 (2003) 223-229
55. Michel C.E., Soloman A.W., Magbanua J.P., et al. Field evaluation of a rapid point-of-care assay for targeting antibiotic treatment for trachoma control: a comparative study. Lancet 367 (2006) 1585-1590
56. Brooker S. Spatial epidemiology of human schistosomiasis in Africa: risk models transmission dynamics and control. Trans R Soc Trop Med Hyg 101 (2007) 1-8
57. Wanji S., Tendongfor N., Esum M., et al. Combined utilisation of rapid assessment procedures for loiasis (RAPLOA) and onchocerciasis (REA) in rain forest villages of Cameroon. Filaria J 4 (2005) 2
58. King J.D., Eigege A., Richards F., et al. Integrating NTD mapping protocols. Can surveys for trachoma and urinary schistosomiasis be done simultaneously?. Am J Trop Med Hyg (2009) in press.
59. Emerson P.M., Ngondi J., Biru E., et al. Integrating an NTD with one of "the big three": combined Malaria and trachoma survey in Amhara region of Ethiopia. PLoS Negl Trop Dis 2 (2008) e197
60. Richards F.O., Eigege A., Miri S., Jinadu M.Y., and Hopkins D.R. Integration of mass drug administration programmes in Nigeria: the challenge of schistosomiasis. Bull World Health Organ 84 (2006) 673-676
61. WHO. Mid level management course for EPI managers. Monitoring routine immunization and data management (2004), World Health Organization, Geneva. http://www.afro.who.int/ddc/vpd/epi_mang_course/pdfs/english/Mod%2020.pd f (accessed June 30, 2009).
62. Baker MC, Trofimovich L, Sankara D, et al. Testing validity of reported drug coverage rates of the neglected tropical disease control program in four countries. ASTMH 57th annual meeting. New Orleans, Dec 8, 2008 (abstr 464).
63. Bockarie M.J. Molecular xenomonitoring of lymphatic filariasis. Am J Trop Med Hyg 77 (2007) 591-592
64. Ngondi J., Gebre T., Shargie E.B., et al. Evaluation of three years of the SAFE strategy (Surgery, Antibiotics, Facial cleanliness and Environmental improvement) for trachoma control in five districts of Ethiopia hyper-endemic for trachoma. Trans R Soc Trop Med Hyg (2009) 10.1016/j.trstmh.2008.11.023 published online Jan 27.
65. Boatin B.A., and Richards Jr. F.O. Control of onchocerciasis. Adv Parasitol 61 (2006) 349-394
66. Koukounari A., Fenwick A., Whawell S., et al. Morbidity indicators of Schistosoma mansoni: relationship between infection and anemia in Ugandan schoolchildren before and after praziquantel and albendazole chemotherapy. Am J Trop Med Hyg 75 (2006) 278-286
67. Mohammed K.A., Haji H.J., Gabrielli A.F., et al. Triple co-administration of ivermectin, albendazole and praziquantel in Zanzibar: a safety study. PLoS Negl Trop Dis 2 (2008) e171
68. Osei-Atweneboana M.Y., Eng J.K.L., Boakye D., et al. Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study. Lancet 369 (2007) 2021-2029
69. Ramzy R.M., El Setouhy M., H Helmy H., et al. Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment. Lancet 367 (2006) 992-999
70. Njenga S.M., Wamae C.N., Mwandawiro C.S., et al. Immuno-parasitological assessment of bancroftian filariasis in a highly endemic area along the River Sabaki, in Malindi district. Ann Trop Med Parasitol 101 (2007) 161-172
71. Report from the Inter-American conference on onchocerciasis, November 2007. Wkly Epidemiol Rec 29 (2007) 256-260
72. Weil G.J., Steel C., Liftis F., et al. A rapid-format antibody card test for diagnosis of onchocerciasis. J Infect Dis 182 (2000) 1796-1799
73. Stingyl P., Ross M., Gibson D.W., et al. A diagnostic 'patch test' for onchocerciasis using topical diethylcarbamazine. Trans R Soc Trop Med Hyg 78 (1984) 254-258
74. Diawara L., Troare M.O., Badji A., et al. Feasibility of Onchocerciasis elimination with ivermectin treatment in Endemic foci in Africa: first evidence from studies in Mali and Senegal. PLoS Negl Trop Dis 3 (2009) e497
75. Bradley M., and Horton J. Assessing the risk of benzimidazole therapy during pregnancy. Trans R Soc Trop Med Hyg 95 (2001) 72-73
76. Boussinesq M., and Gardon J. Prevalences of Loa loa microfilaraemia throughout the area endemic for the infection. Ann Trop Med Parasitol 91 (1997) 573-589
77. Helmy H., Weil G.J., Ellethy A.S., et al. Bancroftian filariasis: effect of repeated treatment with diethylcarbamazine and albendazole on microfilaraemia, antigenaemia and antifilarial antibodies. Trans R Soc Trop Med Hyg 100 (2006) 656-662
78. Taylor M.J., Awadzi K., Basáñez M.G., et al. Onchocerciasis control: vision for the future from a Ghanian perspective. Parasit Vectors 2 (2009) 7
79. Homeida M., Braide E., Elhassan E., et al. APOC's strategy of community-directed treatment with ivermectin (CDTI) and its potential for providing additional health services to the poorest populations, African Programme for Onchocerciasis Control. Ann Trop Med Parasitol 96 (2002) S93-S104
80. Baker M.C., McFarland D.A., Gonzales M., et al. The impact of integrating the elimination programme for lymphatic filariasis into primary health care in the Dominican Republic. Int J Health Plann Manage 22 (2007) 337-352
81. Measure D.H.S. Demographic Health Surveys. http://www.measuredhs.com/aboutsurveys/dhs/start.cfm (accessed March 26, 2009).
82. UNICEF. Multiple Indicator Cluster Survey. http://www.unicef.org/statistics/index_24302.html (accessed March 26, 2009).